Companies are racing to keep pace with the emergence of drug-resistant microorganisms.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Fleming, A. Br. J. Exp. Pathol. 10, 226 ( 1929).
Ganz, T et al. J. Clin. Invest. 76, 1427–1435 (1985).
Ma, Z et al. J. Med. Chem. 42, 4202–4213 (1999).
Wang, G.Y. et al. Org. Lett. 2, 2401–2404 (2000).
Ghannoum, M.A. & Rice, L.B. Clin. Microbiol. Rev. 12, 501–517 (1999).
Ouellette, A.J. Am. J. Physiol. 277, G257–G261. (1999).
Moore, P.A. J. Am. Dent. Assoc. 130, 1341–1343 (1999).
Sreenan, C. & Osiovich, H. Arch. Pediatr. Adolesc. Med. 153, 984–988 (1999).
Kirjavainen, P.V. & Gibson, G.R. Ann. Med. 31, 288–292(1999)
Movahed, M.R. J. S. C. Med. Assoc. 95, 303–308 (1999).
Chen, J. Biopolymers. 55, 88–98 ( 2000).
Blondelle, S.E. & Lohner, K. Biopolymers 55, 74–87 (2000).
Nes, IF & Holo, H. Biopolymers 55, 50–61 (2000).
Hiemstra, P.S. et al. J. Leukoc. Biol. 66, 423– 428 (1999).
Giglione, C. et al. Mol. Microbiol. 36, 1197– 1205 (2000).
Apfel C, et al. J. Med. Chem. 43, 2324–2331 (2000).
Rights and permissions
About this article
Cite this article
Antibacterial and antifungal drug discovery. Nat Biotechnol 18 (Suppl 10), IT24–IT26 (2000). https://doi.org/10.1038/80059
Issue Date:
DOI: https://doi.org/10.1038/80059